Patents by Inventor Steen Guldager Petersen

Steen Guldager Petersen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040086660
    Abstract: The invention relates to a method of providing a solid substrate for immobilizing chemical compounds particular biomolecules. The method comprises the steps of providing a basis substrate, and treating the surface of the basis substrate with a monomer gas in a plasma generated by a power source selected from the group consisting of multiple phase AC supply and multiple DC supply, wherein the intensity of said plasma being at the most 5.0 W/I, such as at the most 3.0 W/I, and said monomer gas comprising one or more types of monomers which is plasma polymerized onto the surface to thereby provide the surface of the solid substrate with chemically reactive groups. The invention also relates to a substrate obtainable by the method, and a process for immobilizing a chemical compound to a surface of such solid substrate. The method is relatively simple and economically feasibly, and the substrate has a high quality and a high concentration of functionalities.
    Type: Application
    Filed: December 4, 2003
    Publication date: May 6, 2004
    Inventors: Bjorn Winther-Jensen, Soren Flygenring Christensen, Steen Guldager Petersen
  • Patent number: 6372477
    Abstract: A UDP-galactose epimerase enzyme is described. In addition, there is described a nucleotide sequence coding for the same.
    Type: Grant
    Filed: January 24, 2000
    Date of Patent: April 16, 2002
    Assignee: Danisco A/S
    Inventors: Morten J&thgr;rsboe, Janne Brunstedt, Steen Guldager Petersen
  • Patent number: 5767378
    Abstract: The present invention provides a method for identifying or selecting from a population of eukaryotic cells cultivated on or in a medium containing at least one compound, cells which have a metabolic advantage as a result of having being transformed, wherein:i) the cells are transformed with a nucleotide sequence or a co-introduced nucleotide sequence one of which comprises a region which: (a) encodes a protein which is involved in the metabolism of the compound, and/or (b) regulates the activity of the protein; andii) the compound is mannose or xylose or a derivative or a precursor of these, or a substrate of the protein, or is capable of being metabolized by the transformed cells into such a substrate, with the proviso that the compound is not mannose when the protein is mannose 6 phosphate isomerase.
    Type: Grant
    Filed: October 3, 1995
    Date of Patent: June 16, 1998
    Assignee: Novartis AG
    Inventors: Kirsten Bojsen, Iain Donaldson, Anna Haldrup, Morten Joersboe, Jette Dina Kreiberg, John Nielsen, Finn Thyge Okkels, Steen Guldager Petersen